26 November 2007 in Oncogene
1 April 2004 in Journal of Neuropathology & Experimental Neurology
Over the past 5 to 10 years, important advances were made in the understanding of meningioma biology. Progress in molecular genetics probably represents the most important accomplishment in the comprehensive knowledge of meningioma pathogenesis. Several genes could be identified as targets for mutation or inactivation. Additional chromosomal regions were found to be commonly deleted or amplified, suggesting the presence of further tumor suppressor genes or proto-oncogenes, respectively, in these regions. Histopathologically, the most important innovation is represented by the revised WHO classification in the year 2000. Meningioma grading criteria in the new classification scheme are more precise and objective, and should thus improve consistency in predicting tumor recurrence and aggressive behavior. This review focuses mainly on the advances in molecular biology that were achieved in recent years. It summarizes the most important aspects of meningioma classification as the basis to place biological observations into a correlative context, and, further, includes mechanisms of angiogenesis and edema formation as well as the role of hormone receptors in meningiomas.
5 September 2013 in Acta Neuropathologica
18 May 2007 in International Journal of Cancer
The c‐Met receptor and its ligand scatter factor/hepatocyte growth factor (SF/HGF) are strongly overexpressed in malignant gliomas. Signaling through c‐Met as well as exposure to hypoxia can stimulate glioma cell migration and invasion. In several cancer cell types, hypoxia was shown to activate the c‐met promoter, which contains hypoxia inducible factor‐1 (HIF‐1) binding sites. We hypothesized that hypoxia might upregulate c‐Met also in glioma cells. Analyzing 18 different glioblastoma cell lines and 10 glioblastoma primary cultures, we found that in 50% of both the cell lines and the primary cultures c‐Met protein levels were increased following exposure to hypoxia. Upregulation of c‐met in response to hypoxia was also detected at the transcriptional level. In all primary cultures and in 16 of the 18 cell lines (89%), HIF‐1α levels were increased by hypoxia. Transfection of siRNA against HIF‐1α abgrogated the hypoxic induction of c‐Met, suggesting that c‐Met expression is upregulated by a HIF‐1α‐dependent mechanism. Hypoxia sensitized glioblastoma cell lines which showed hypoxic induction of c‐Met to the motogenic effects of SF/HGF. These findings suggest that approximately half of all human glioblastomas respond to hypoxia with an induction of c‐Met, which can enhance the stimulating effect of SF/HGF on tumor cell migration.
1 June 2003 in Neurosurgery
MBMarc-Alexander Brockmann
OBJECTIVE. Glioma cell migration is determined by a complex interplay between soluble motogens and extracellular matrix components. Several growth facto